Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver dysfunction without an increase in major bleeding events, according to data presented at ...
Spleen stiffness measurement (SSM) offers a noninvasive method to diagnose portal hypertension in BCR::ABL1-negative MPN patients, potentially improving patient management. SSM captures hepatic ...
Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal hypertension (PH) being a primary driver of disease progression and ...
SAN DIEGO — Patients with cirrhosis treated with sodium-glucose cotransporter 2 (SGLT2) inhibitors show significant reductions in a range of portal hypertension complications and all-cause mortality ...
Portal hypertensive gastropathy (PHG) is a condition in which the gastric mucosal area is subjected to friability. This condition leads to changes in gastric mucosa, which normally occurs due to ...
APPLICATION of the technics of hepatic-vein catheterization and percutaneous splenic puncture, with appropriate blood-flow and pressure measurements and radiologic visualization of the portal bed, has ...
Simvastatin could be an effective therapy for portal hypertension, according to a study by Abraldes and colleagues, which shows that the drug decreases portal hypertension and improves liver perfusion ...
MASH patients exhibit a higher spleen-to-liver stiffness ratio than ALD patients, indicating a presinusoidal component in portal hypertension. The study found that MASH patients have larger spleen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback